Skip Ribbon Commands
Skip to main content
Sign In
Navigate Up

26153 Pain Clinic Survey 4 Without Confirmation, Urine

Pain Clinic Survey 4 Without Confirmation, Urine
Test Code: PCS4WO
Synonyms/Keywords
​Drug screen, drug test, barbiturates, cannabinoids, marijuana, THC, cocaine, ethanol
Test Components

Immunoassay screen for the following drug classes or method groups: barbiturates, cannabinoids, cocaine, and ethanol. Test also includes specimen validity testing (creatinine) to detect adulteration, dilution, or substitution of the specimen.

Results of this test are presumptive. If confirmatory testing is desired, the confirmatory test(s) can be ordered as add-on (u-have) tests, utilizing the original urine collection, within 9 days of the original test.

This test is intended to compliment the test “Targeted Drug Panel, Urine” (TDPU).

Useful For

Immunoassay screen (presumptive results) for tests not covered in the “Targeted Drug Panel, Urine” (TDPU).

Specimen Requirements
Fasting Required Specimen Type Preferred Container/Tube Acceptable Container/Tube Specimen Volume Specimen Minimum Volume
(allows for 1 repeat)		 Pediatric Minimum Volume
(no repeat)
​No ​Urine​Clean plastic container​​5 mL​1.5 mL​1.5 mL
Specimen Stability Information

Specimen Type Temperature Time
​Urine ​ ​Refrigerated 
 ​3 days
​Frozen
 ​>3 days
Interference
Immunoassay is useful in detecting truly negative samples. However, each immunoassay is more sensitive to some components of the drug class than others, and cross-reactivity of other substances can interfere or alter results. Therefore, this test is intended to be used by a physician or trained provider and interpreted in the context of the patient's symptoms and history.
Performing Laboratory Information
Performing Location Day(s) Test Performed Analytical Time Methodology/Instrumentation
​Marshfield ​Monday through Friday​1 days​Beckman DxC 700 AU/Emit Immunoassay
Test Information
This is a screening-only assay performed on urine specimens and is designed to support medical, not forensic, purposes. The detection of drug classes listed in this survey is to be used for compliance monitoring and identification of abuse.

This test recognizes the following drug classes utilizing immunoassay reagents: barbiturates, cannabinoids, cocaine, and ethanol. Test includes specimen validity testing (creatinine) to detect adulteration, dilution, or substitution of the specimen.​

Immunoassay is useful in detecting truly negative samples. However, each immunoassay is more sensitive to some components of the drug class than others, and cross-reactivity of other substances can interfere or alter results. Therefore, this test is intended to be used by a physician or trained provider and interpreted in the context of the patient's symptoms and history.

Positive results are not definitive, and should be considered presumptive. Any presumptive positive results should be confirmed before the results are acted upon. The advantage of this test is that it is low-cost to the patient, and in most cases will give enough information to determine if the patient is adhering to the guidelines of their particular pain management program.

Specimens are kept for 9 business days from the screening date. If confirmation testing is desired to accurately determine what drugs the patient is positive for, please or the additional testing or call the laboratory at 93734 within this timeframe. If specimen is available, confirmation testing can be ordered at an additional charge. For specific details of what drugs are detected in each confirmation assay, please refer to the information provided with those specific test codes or inquire with the laboratory's technical staff before ordering. ​

Reference Range Information
Performing Location Reference Range
​Marshfield ​No reference range for drugs found in urine.  Presence of drug indicates ingestion/use only, and is not to be used for therapeutic drug monitoring.
Interpretation

Drug classes are reported as “Presumptive Positive” or “Negative”. Specific drugs within these drug classes are not reported, and would require confirmatory testing if this information is desired.

Results should be confirmed before acting on results.

Outreach CPTs
CPT Modifier
(if needed)		 Quantity Description Comments
​80307 ​ ​1 ​​Drug test(s), presumptive, any number of drug classes, qualitative; any number of devices or
procedures, by instrument chemistry and analyzers (e.g., utilizing immunoassay [EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]),
chromatography (e.g., GC, HPLC), and mass spectrometry either with or without chromatography		 ​
Synonyms/Keywords
​Drug screen, drug test, barbiturates, cannabinoids, marijuana, THC, cocaine, ethanol
Test Components

Immunoassay screen for the following drug classes or method groups: barbiturates, cannabinoids, cocaine, and ethanol. Test also includes specimen validity testing (creatinine) to detect adulteration, dilution, or substitution of the specimen.

Results of this test are presumptive. If confirmatory testing is desired, the confirmatory test(s) can be ordered as add-on (u-have) tests, utilizing the original urine collection, within 9 days of the original test.

This test is intended to compliment the test “Targeted Drug Panel, Urine” (TDPU).

Ordering Applications

Ordering Application Description
​Cerner ​Pain Clinic 4 w/o Confirm
If the ordering application you are looking for is not listed, contact your local laboratory for assistance.
Specimen Requirements
Fasting Required Specimen Type Preferred Container/Tube Acceptable Container/Tube Specimen Volume Specimen Minimum Volume
(allows for 1 repeat)		 Pediatric Minimum Volume
(no repeat)
​No ​Urine​Clean plastic container​​5 mL​1.5 mL​1.5 mL
Specimen Stability Information

Specimen Type Temperature Time
​Urine ​ ​Refrigerated 
 ​3 days
​Frozen
 ​>3 days
Interference
Immunoassay is useful in detecting truly negative samples. However, each immunoassay is more sensitive to some components of the drug class than others, and cross-reactivity of other substances can interfere or alter results. Therefore, this test is intended to be used by a physician or trained provider and interpreted in the context of the patient's symptoms and history.
Useful For

Immunoassay screen (presumptive results) for tests not covered in the “Targeted Drug Panel, Urine” (TDPU).

Test Components

Immunoassay screen for the following drug classes or method groups: barbiturates, cannabinoids, cocaine, and ethanol. Test also includes specimen validity testing (creatinine) to detect adulteration, dilution, or substitution of the specimen.

Results of this test are presumptive. If confirmatory testing is desired, the confirmatory test(s) can be ordered as add-on (u-have) tests, utilizing the original urine collection, within 9 days of the original test.

This test is intended to compliment the test “Targeted Drug Panel, Urine” (TDPU).

Reference Range Information
Performing Location Reference Range
​Marshfield ​No reference range for drugs found in urine.  Presence of drug indicates ingestion/use only, and is not to be used for therapeutic drug monitoring.
Interpretation

Drug classes are reported as “Presumptive Positive” or “Negative”. Specific drugs within these drug classes are not reported, and would require confirmatory testing if this information is desired.

Results should be confirmed before acting on results.

For more information visit:
Performing Laboratory Information
Performing Location Day(s) Test Performed Analytical Time Methodology/Instrumentation
​Marshfield ​Monday through Friday​1 days​Beckman DxC 700 AU/Emit Immunoassay
For billing questions, see Contacts
Outreach CPTs
CPT Modifier
(if needed)		 Quantity Description Comments
​80307 ​ ​1 ​​Drug test(s), presumptive, any number of drug classes, qualitative; any number of devices or
procedures, by instrument chemistry and analyzers (e.g., utilizing immunoassay [EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]),
chromatography (e.g., GC, HPLC), and mass spectrometry either with or without chromatography		 ​
For most current information refer to the Marshfield Laboratory online reference manual.